Form 4: Director Curt Anastasio Reports Core Laboratories Stock Transactions

Director Curt Anastasio of Core Laboratories Inc. reported transactions involving restricted shares, with a portion vesting and a new grant of restricted shares.

Summary

• Director Curt Anastasio of Core Laboratories Inc. reported a transaction on April 1, 2026.
• 8,069 shares of Common Stock were acquired.
• This acquisition resulted in a total of 23,805 shares beneficially owned.
• A grant of 7,895 Restricted Shares was made, which will vest on April 1, 2027, subject to a one-year vesting period and a deferral election.
• Another 8,069 Restricted Shares vested on April 1, 2026, after completing a one-year vesting period.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it primarily reports routine vesting and grant of restricted shares by a director, without indicating significant buying or selling pressure.

Positives

• Director Curt Anastasio received a grant of 7,895 restricted shares, indicating continued incentive alignment.
• 8,069 restricted shares vested, demonstrating the fulfillment of prior vesting conditions.

Risks

• The newly granted restricted shares are subject to a deferral election by the Reporting Person in accordance with Treasury Regulation 1.409A-2, which could impact the timing of distribution.
• The vesting of restricted shares is subject to the terms of issuance, implying potential conditions that could affect vesting.

Future Outlook

The filing indicates that 7,895 restricted shares granted will vest on April 1, 2027, subject to a one-year vesting period and a deferral election. The vested portion will be distributed following the Reporting Person's separation of service from the Board.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the holdings and activities of company directors and officers. These filings are crucial for investors seeking to understand insider sentiment and potential shifts in beneficial ownership within a company like Core Laboratories Inc.

Stakeholder Impact

• Shareholders gain insight into director compensation and equity incentives through the grant and vesting of restricted shares.
• The deferral election for new restricted shares may impact the immediate liquidity for the director but aligns with long-term retention and service.

Next Steps

• Distribution of vested restricted shares following the Reporting Person's separation of service from the Board.

Key Dates

Keywords

SEC Form 4, Core Laboratories Inc., CLB, Director Transactions, Beneficial Ownership, Restricted Shares, Stock Vesting, Insider Trading